Non Obstructive Versus Obstructive Coronary Artery Disease
February 13, 2023 updated by: Hasanain Ali Al ftailah, Arab Board of Health Specializations, Iraq
Non Obstructive Versus Obstructive Coronary Artery Disease Documented by Coronary Angiography; Prevalence & Diagnostic Features in a Single Center Experience : A Prospective Cross Sectional Study
The goal of this observational study is to study the non obstructive type of ischemic heart disease by identifying unique clinical features , frequency and age group .in patient admitted in coronary care unit , suffered from angina or heart attack. . The main question[s] it aims to answer are:
- how it different from classical type of ischemic heart disease ( obstructive coronary artery disease)
- what is frequency and age prevalence of these patient Participants evaluated by history , clinical examination, serum troponin and coronary angiography.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
167
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Karbala, Iraq, 56001
- Arab board of health specializations-Iraq, Karbala , Iraq
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 81 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
all patients with clinical features of IHD underwent coronary angiography in CCU of imam hussain hospital from January to May of 2021
Description
Inclusion Criteria:
- Patients diagnosed with IHD ( MI, unstable angina ,chronic stable angina)
- >18 years of age
- patients undergoing CAG for emergency or elective situations.
Exclusion Criteria:
- Patients who were hemodynamically unstable.
- patients with incomplete data
- patients with clinical features of pericarditis or others of non cardiac origin chest pain .
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Non obstructive versus obstructive coronary artery disease documented by coronary angiography; prevalence & diagnostic features in a single center experience : A prospective cross sectional study
Time Frame: BASELINE
|
analysis of diagnostic features and frequency of non obstructive artery disease in comparison to obstructive artery disease
|
BASELINE
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2022
Primary Completion (Actual)
May 1, 2022
Study Completion (Actual)
February 11, 2023
Study Registration Dates
First Submitted
February 13, 2023
First Submitted That Met QC Criteria
February 13, 2023
First Posted (Estimate)
February 22, 2023
Study Record Updates
Last Update Posted (Estimate)
February 22, 2023
Last Update Submitted That Met QC Criteria
February 13, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NOCAD diagnostic features
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.